Publications by authors named "Elizabeth Reap"

Claim this Profile
A
A peptide vaccine targeting the CMV antigen pp65 in children and young adults with recurrent high-grade glioma and medulloblastoma: a phase 1 trial.
Eric M Thompson, David M Ashley, Katayoun Ayasoufi, Pamela Norberg, Gerald Archer, Elizabeth Reap

Nat Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and Stability of New Class of Fetal Bovine Sera (FBS) and Its Lyophilized Form in ELISpot and FluoroSpot Assays: Applications for Monitoring the Immune Response in Vaccine, and Cell and Gene Immunotherapy in Clinical Trials.
Zhinous Hosseini, Christopher J Groves, Penny Anders, Kristen Cave, Madelyn Krunkosky, Elizabeth Reap

Methods Mol Biol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.
Luis Sanchez-Perez, Carter M Suryadevara, Bryan D Choi, Elizabeth A Reap, John H Sampson

Oncoimmunology· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI).
Leah S Price, Matthew Adamow, Sebastian Attig, Peter Fecci, Pamela Norberg, Elizabeth Reap

Cytometry A· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts.
Carter M Suryadevara, Rupen Desai, S Harrison Farber, Bryan D Choi, Adam M Swartz, Elizabeth A Reap

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD27 stimulation unveils the efficacy of linked class I/II peptide vaccines in poorly immunogenic tumors by orchestrating a coordinated CD4/CD8 T cell response.
Katherine A Riccione, Li-Zhen He, Peter E Fecci, Pamela K Norberg, Carter M Suryadevara, Elizabeth Reap

Oncoimmunology· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant Glioma.
Patrick C Gedeon, Teilo H Schaller, Satish K Chitneni, Bryan D Choi, Chien-Tsun Kuan, Elizabeth A Reap

Clin Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simple and enzyme-free method for processing infiltrating lymphocytes from small mouse tumors for ELISpot analysis.
Adam M Swartz, Elizabeth Reap, Pamela Norberg, Robert Schmittling, Sylvia Janetzki

J Immunol Methods· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Elizabeth A Reap, Carter M Suryadevara, Kristen A Batich, Luis Sanchez-Perez, Gary E Archer

Cancer Res· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
Sridharan Gururangan, Elizabeth Reap, Robert Schmittling, Mehmet Kocak, Renee Reynolds

Cancer Immunol Immunother· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Supramolecular Vaccine Platform Based on α-Helical Peptide Nanofibers.
Yaoying Wu, Pamela K Norberg, Elizabeth A Reap, Kendra L Congdon, Chelsea N Fries

ACS Biomater Sci Eng· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination.
Kristen A Batich, Elizabeth A Reap, Gary E Archer, Luis Sanchez-Perez, Smita K Nair

Clin Cancer Res· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.
Anirudh Saraswathula, Elizabeth A Reap, Bryan D Choi, Robert J Schmittling, Pamela K Norberg

Cancer Immunol Immunother· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe adverse immunologic reaction in a patient with glioblastoma receiving autologous dendritic cell vaccines combined with GM-CSF and dose-intensified temozolomide.
Duane A Mitchell, Elias J Sayour, Elizabeth Reap, Robert Schmittling, Gabriel DeLeon

Cancer Immunol Res· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Duane A Mitchell, Kristen A Batich, Michael D Gunn, Min-Nung Huang, Luis Sanchez-Perez, Elizabeth A Reap

Nature· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy for malignant glioma.
Carter M Suryadevara, Terence Verla, Luis Sanchez-Perez, Elizabeth A Reap, Bryan D Choi

Surg Neurol Int· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EGFRvIII mCAR-modified T-cell therapy cures mice with established intracerebral glioma and generates host immunity against tumor-antigen loss.
John H Sampson, Bryan D Choi, Luis Sanchez-Perez, Carter M Suryadevara, David J Snyder, Elizabeth A Reap

Clin Cancer Res· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human regulatory T cells kill tumor cells through granzyme-dependent cytotoxicity upon retargeting with a bispecific antibody.
Bryan D Choi, Patrick C Gedeon, James E Herndon, Gary E Archer, Elizabeth A Reap

Cancer Immunol Res· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
Luis Sanchez-Perez, Bryan D Choi, Elizabeth A Reap, Elias J Sayour, Pamela Norberg

Cancer Immunol Immunother· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma.
Richard A Morgan, Laura A Johnson, Jeremy L Davis, Zhili Zheng, Kevin D Woolard, Elizabeth A Reap

Hum Gene Ther· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma.
John H Sampson, Robert J Schmittling, Gary E Archer, Kendra L Congdon, Smita K Nair, Elizabeth A Reap

PLoS One· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.
David I Bernstein, Elizabeth A Reap, Kevin Katen, Aubrey Watson, Kaitlin Smith

Vaccine· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preclinical evaluation of an alphavirus replicon vaccine for influenza.
Bolyn Hubby, Todd Talarico, Maureen Maughan, Elizabeth A Reap, Peter Berglund

Vaccine· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus.
Elizabeth A Reap, John Morris, Sergey A Dryga, Maureen Maughan, Todd Talarico

Vaccine· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Elizabeth A Reap, Sergey A Dryga, John Morris, Bryan Rivers, Pamela K Norberg

Clin Vaccine Immunol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis